BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:01 PM
 | 
Feb 01, 2008
 |  BC Extra  |  Company News

Roche seeks clearance to sell Mircera

Roche (SWX:ROG) is seeking a U.S. court's clearance to sell Mircera methoxy polyethylene glycol-epoetin beta to treat anemia associated with chronic renal failure. In a request submitted to the U.S. District Court for the District of Massachusetts on Jan. 28, Roche proposed paying Amgen a royalty of 20% and...

Read the full 242 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >